Akari Therapeutics, Plc (AKTX) Balance Sheet
AKTX balance sheet, 2025
December 31, 2025 · U.S. dollars$47.9M assets = $19.6M liabilities + $28.3M equity
Both columns are drawn to the same scale: what AKTX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
AKTX financial health
Descriptive bands, not a rating. Fiscal 2025.
AKTX balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $45.9M2016 | $47.9M2025 | +0.5%/yr | |
| Total liabilities | $11.8M2016 | $19.6M2025 | +5.8%/yr | |
| Shareholders’ equity | $34.1M2016 | $28.3M2025 | −2.0%/yr | |
| Cash & short-term investments | $44.1M2016 | $5.2M2025 | −21.1%/yr | |
| Total debt | $3.3M2024 | $754,0002025 | −76.9%/yr | |
| Net cash (debt) | −$661,0002024 | $4.4M2025 | +$5.1M | |
| Working capital | $33.9M2016 | −$6.9M2025 | −$40.8M | |
| Current ratio | 3.902016 | 0.442025 | −3.45 | |
| Debt / equity | 0.152024 | 0.032025 | −0.12 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
AKTX assets
AKTX liabilities and equity
AKTX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
AKTX balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $5.2M | $2.6M | $3.8M | $13.2M | $9.4M | $14.1M | $5.7M | $6.0M | $28.1M | $44.1M |
| Cash & equivalents | $5.2M | $2.6M | $3.8M | $13.2M | $9.4M | $14.1M | $5.7M | $6.0M | $28.1M | $34.1M |
| Short-term investments | — | — | — | — | — | — | — | — | $0 | $10.0M |
| Receivables | $0 | $201,000 | $0 | $3.0M | $0 | $3.5M | $4.5M | $10.4M | $0 | $0 |
| Inventory | $0 | $0 | $0 | −$2.5M | $0 | −$521,880 | −$1.0M | −$2.0M | $0 | $0 |
| Other current assets | $259,000 | $152,000 | $496,000 | $99,756 | $2.3M | $0 | $1.0M | $2.0M | $706,415 | $1.5M |
| Total current assets | $5.5M | $3.0M | $4.3M | $13.8M | $11.6M | $14.6M | $10.3M | $16.4M | $28.8M | $45.6M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $5,000 | $20,000 | $55,898 | $58,364 |
| Goodwill & intangible assets | $42.4M | $47.6M | $14,000 | $17,000 | $22,929 | $27,150 | $30,000 | $33,000 | $39,124 | $39,365 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $142,235 | $142,168 |
| Total assets | $47.9M | $50.6M | $4.4M | $13.8M | $11.6M | $14.6M | $10.3M | $16.5M | $29.1M | $45.9M |
| Liabilities | ||||||||||
| Accounts payable | $8.8M | $12.4M | $1.7M | $947,000 | $1.8M | $3.4M | $1.2M | $1.6M | $2.0M | $2.2M |
| Short-term debt | $754,000 | $3.3M | — | — | — | — | — | — | — | — |
| Total current liabilities | $12.4M | $19.9M | $4.6M | $12.0M | $6.1M | $5.2M | $5.5M | $3.1M | $9.0M | $11.7M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $7.2M | $8.4M | $0 | $946,658 | $4.3M | $3.4M | $1.0M | $48,003 | $48,003 | $56,360 |
| Total liabilities | $19.6M | $28.3M | $4.6M | $12.0M | $6.1M | $5.2M | $6.5M | $3.1M | $9.1M | $11.8M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | — | $5.3M | $1.3M | $745,000 | $475,973 | $384,733 | $32.0M | $23.7M | $22.9M | $18.3M |
| Retained earnings (deficit) | −$264.6M | −$247.3M | −$227.5M | −$217.5M | −$199.7M | −$182.3M | −$138.2M | −$116.5M | −$107.5M | −$74.9M |
| Accumulated other comprehensive income | −$782,000 | −$738,000 | $51.2M | $51.4M | $51.7M | −$648,065 | −$12.2M | −$12.2M | −$236,246 | −$280,097 |
| Total shareholders' equity | $28.3M | $22.2M | −$229,000 | $1.8M | $5.6M | $9.4M | $3.8M | $13.4M | $20.0M | $34.1M |
| Key figures | ||||||||||
| Total debt | $754,000 | $3.3M | — | — | — | — | — | — | — | — |
| Net cash (debt) | $4.4M | −$661,000 | — | — | — | — | — | — | — | — |
| Working capital | −$6.9M | −$17.0M | −$243,000 | $1.8M | $5.5M | $9.4M | $4.8M | $13.3M | $19.8M | $33.9M |
| Tangible book value | −$14.1M | −$25.4M | −$243,000 | $1.8M | $5.5M | $9.4M | $3.8M | $13.3M | $19.9M | $34.1M |
| Current ratio | 0.44 | 0.15 | 0.95 | 1.15 | 1.91 | 2.79 | 1.88 | 5.33 | 3.19 | 3.90 |
| Quick ratio | 0.42 | 0.14 | 0.84 | 1.35 | 1.54 | 3.37 | 1.88 | 5.33 | 3.11 | 3.77 |
| Debt / equity | 0.03 | 0.15 | — | — | — | — | — | — | — | — |
| Equity / assets | 59.1% | 44.0% | −5.3% | 12.9% | 47.7% | 64.3% | 37.2% | 81.3% | 68.8% | 74.3% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $7.7M | $2.8M | $5.2M | $2.5M | $2.7M | $2.6M | $2.6M | $2.2M | $4.2M | $1.3M | $3.8M | $3.8M |
| Cash & equivalents | $7.7M | $2.8M | $5.2M | $2.5M | $2.7M | $2.6M | $2.6M | $2.2M | $4.2M | $1.3M | $3.8M | $3.8M |
| Receivables | $0 | $0 | $0 | $0 | $0 | $201,000 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $630,000 | $821,000 | $259,000 | $462,000 | $590,000 | $566,000 | $353,000 | $488,000 | $899,000 | $1.5M | $496,000 | $496,000 |
| Total current assets | $8.3M | $3.6M | $5.5M | $2.9M | $3.3M | $3.3M | $3.0M | $2.7M | $5.1M | $2.8M | $4.3M | $4.3M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $30.3M | $30.3M | $42.4M | $42.4M | $47.6M | $47.6M | $47.6M | $0 | $0 | $0 | $14,000 | $14,000 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total assets | $38.6M | $33.9M | $47.9M | $45.4M | $50.9M | $51.0M | $50.6M | $2.7M | $5.1M | $2.8M | $4.4M | $4.4M |
| Liabilities | ||||||||||||
| Accounts payable | $9.4M | $8.6M | $8.8M | $10.8M | $11.6M | $13.1M | $12.4M | $4.8M | $4.7M | $3.2M | $1.7M | $1.7M |
| Short-term debt | $693,000 | $732,000 | $754,000 | $2.1M | $1.5M | $1.8M | — | $1.0M | $1.0M | — | — | — |
| Deferred revenue | — | — | — | — | — | — | — | — | −$5.7M | — | — | — |
| Total current liabilities | $13.9M | $13.4M | $12.4M | $15.6M | $17.1M | $20.9M | $19.9M | $9.4M | $8.8M | $6.3M | $4.6M | $4.6M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $6.1M | $6.1M | $7.2M | $7.1M | $8.2M | $8.3M | $8.4M | $0 | $0 | $0 | $0 | $0 |
| Total liabilities | $20.0M | $19.5M | $19.6M | $22.7M | $25.3M | $29.2M | $28.3M | $9.4M | $8.8M | $6.3M | $4.6M | $4.6M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $1,000 | — | — | $6.5M | $6.5M | $5.8M | — | $2.4M | $2.4M | $1.6M | $1.3M | $1.3M |
| Retained earnings (deficit) | −$283.8M | −$279.0M | −$264.6M | −$259.3M | −$252.9M | −$251.0M | −$247.3M | −$243.5M | −$240.6M | −$233.0M | −$227.5M | −$227.5M |
| Accumulated other comprehensive income | −$695,000 | −$768,000 | −$782,000 | −$1.1M | −$1.1M | −$773,000 | — | −$926,000 | −$749,000 | −$761,000 | $51.2M | $51.2M |
| Total shareholders' equity | $18.6M | $14.4M | $28.3M | $22.7M | $25.6M | $21.7M | $22.2M | −$6.7M | −$3.7M | −$3.6M | −$229,000 | −$229,000 |
| Key figures | ||||||||||||
| Total debt | $693,000 | $732,000 | $754,000 | $2.1M | $1.5M | $1.8M | — | $1.0M | $1.0M | — | — | — |
| Net cash (debt) | $7.0M | $2.0M | $4.4M | $367,000 | $1.2M | $736,000 | — | $1.2M | $3.2M | — | — | — |
| Working capital | −$5.6M | −$9.8M | −$6.9M | −$12.6M | −$13.8M | −$17.6M | −$17.0M | −$6.7M | −$3.7M | −$3.6M | −$243,000 | −$243,000 |
| Tangible book value | −$11.7M | −$15.9M | −$14.1M | −$19.7M | −$22.0M | −$25.9M | −$25.4M | −$6.7M | −$3.7M | −$3.6M | −$243,000 | −$243,000 |
| Book value per share | $10.38 | — | — | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 1.8M | — | — | — | — | — | — | — | — | — | — | — |
| Current ratio | 0.60 | 0.27 | 0.44 | 0.19 | 0.19 | 0.16 | 0.15 | 0.29 | 0.58 | 0.44 | 0.95 | 0.95 |
| Quick ratio | 0.55 | 0.21 | 0.42 | 0.16 | 0.16 | 0.13 | 0.13 | 0.24 | 0.48 | 0.21 | 0.84 | 0.84 |
| Debt / equity | 0.04 | 0.05 | 0.03 | 0.09 | 0.06 | 0.08 | — | — | — | — | — | — |
| Equity / assets | 48.1% | 42.4% | 59.1% | 50.0% | 50.3% | 42.7% | 44.0% | −244.8% | −73.0% | −128.2% | −5.3% | −5.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 30, 2026); data from EODHD.
AKTX financial position
At the end of fiscal 2025 (December 31, 2025), Akari Therapeutics, Plc had total assets of $47.9 million (down 5.3% from a year earlier), total liabilities of $19.6 million and shareholders' equity of $28.3 million. It held $5.2 million in cash and short-term investments against $0.8 million of debt, a net cash position of $4.4 million. Its current ratio was 0.44. In the latest quarter (ended June 30, 2026) total assets were $38.6 million and equity $18.6 million.
Related: AKTX income statement, AKTX cash flow statement, AKTX key metrics. See the AKTX stock overview for the latest quote and news.
AKTX balance sheet FAQ
What are Akari Therapeutics, Plc's total assets?
Akari Therapeutics, Plc reported total assets of $47.9 million at the end of fiscal 2025 (December 31, 2025), compared with $50.6 million a year earlier.
How much debt does Akari Therapeutics, Plc have?
Akari Therapeutics, Plc had $0.8 million of total debt at the end of fiscal 2025, including short-term borrowings. Its debt-to-equity ratio was 0.03.
How much cash does Akari Therapeutics, Plc have?
Akari Therapeutics, Plc held $5.2 million in cash and short-term investments at the end of fiscal 2025; with $0.8 million of debt that is net cash of $4.4 million.
What is Akari Therapeutics, Plc's book value?
Akari Therapeutics, Plc's shareholders' equity (book value) was $28.3 million at the end of fiscal 2025.
What is Akari Therapeutics, Plc's current ratio?
Akari Therapeutics, Plc had current assets of $5.5 million and current liabilities of $12.4 million, a current ratio of 0.44 (current liabilities exceed current assets).
How much goodwill does Akari Therapeutics, Plc have?
Akari Therapeutics, Plc carried $42.4 million of goodwill and intangible assets, 88.6% of total assets, at the end of fiscal 2025.